Weatherly Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Weatherly Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,917	Closed	-$209K	–	181
2019 Q2	$209K	Hold	1,917	–	–	0.04%	187
2019 Q1	$214K	Buy	+1,917	New	+$210K	0.04%	181
2018 Q4	–	Sell	-1,917	Closed	-$234K	–	182
2018 Q3	$234K	Hold	1,917	–	–	0.05%	184
2018 Q2	$211K	Hold	1,917	–	–	0.05%	186
2018 Q1	$205K	Hold	1,917	–	–	0.05%	191
2017 Q4	$205K	Hold	1,917	–	–	0.05%	198
2017 Q3	$213K	Buy	+1,917	New	+$205K	0.06%	177

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Weatherly Asset Management's IBB Position: Q3 2019 in Review

Weatherly Asset Management sold out of iShares Biotechnology ETF (IBB) in Q3 2019, closing a stake of 1,917 shares — an estimated $209K sold.

Weatherly Asset Management first reported a position in IBB in Q3 2017 and held it in 7 quarters. The position peaked at $234K in Q3 2018. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

Weatherly Asset Management reported no remaining iShares Biotechnology ETF position as of Q3 2019 after selling out during the quarter.
Weatherly Asset Management sold 1,917 iShares Biotechnology ETF shares in Q3 2019, an estimated $209K.
Weatherly Asset Management first reported a position in iShares Biotechnology ETF in Q3 2017 and held it in 7 quarters.
Weatherly Asset Management's iShares Biotechnology ETF position peaked at $234K in Q3 2018.
597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Weatherly Asset Management's 13F filing for Q3 2019, filed 7 Nov 2019.